IL17A and inflammatory bowel disease: Additionally, no SAEs or AEs of special interest were observed, including new onset of IBD (ulcerative colitis or Crohn’s disease) previously reported with antibodies that target IL-17 signaling [37], or suicidal ideation, previously reported with brodalumab [23].